The article reviews contemporary data on role of the coronary artery bypass grafting (CABG) in patients with stable ischemic heart disease. The principles of pre-surgery risk assessment and choice between CABG and percutaneous coronary intervention are provided. Based on the results of the controlled studies, the indications for CABG were established in guidelines. The evaluation of the myocardial viability and coronary reserve may improve patient selection for revascularization procedures. Evidence base regarding predictors of early postoperative complications and results of the long-term observation of patients after CABG is provided. Possible intermediate ctiteria of revascularization efficiency are changes of left ventricular pump function and quality of life parameters. A special attention is devoted to the perspectives of new surgical technologies to improve CABG results.